Issue 44, 2021

Suppressing barite crystallization with organophosphorus compounds

Abstract

Molecular modifiers can display a wide range of interactions with crystal interfaces to impede their growth. In this work we evaluate the efficacy of a naturally derived phosphorous-containing molecule, phytate, as an inhibitor of barite crystallization compared to the performance of a commercial organophosphorus standard. We show that both compounds inhibit barite nucleation and growth, with phytate demonstrating enhanced potency over the benchmark compound. Our findings reveal that phytate operates by a distinct mode of action on multiple crystal facets, imparting exceptional efficacy, which combined with its biocompatibility and widespread availability make phytate a potentially viable environmentally-friendly alternative to current barite scale treatments.

Graphical abstract: Suppressing barite crystallization with organophosphorus compounds

Supplementary files

Article information

Article type
Paper
Submitted
20 jun 2021
Accepted
07 okt 2021
First published
07 okt 2021

CrystEngComm, 2021,23, 7725-7730

Author version available

Suppressing barite crystallization with organophosphorus compounds

R. D. Sosa, J. C. Conrad, M. A. Reynolds and J. D. Rimer, CrystEngComm, 2021, 23, 7725 DOI: 10.1039/D1CE00813G

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements